Myopia, or short-sightedness, is on the rise among children globally, with experts warning of a looming health crisis. A recent global study reveals that 35% of children are currently affected, a ...
Myopia in children is on the rise. The condition, also known as shortsightedness, affects up to 35% of children across the ...
Myopia, or nearsightedness, is increasingly affecting children globally, with predictions indicating it will impact over 740 million kids by 2050. Left untreated, myopia can lead to severe eye health ...
The drug, a low-dose atropine, was being tested with the company's experimental drug-delivery device, Optejet, as a potential ...
On Friday, Eyenovia, Inc. (NASDAQ:EYEN) stock is trading lower after an update from the Phase 3 CHAPERONE study evaluating ...
Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination ...
Parents hold a ton of the blame in the rising levels of nearsightedness in children. We can all do more to protect our vision ...
A recent inquiry into the effects of Covid-19 on young people compares relaxed pandemic approach of Sweden with that of ...
Eyenovia (EYEN) announced that a review of the CHAPERONE data by an independent Data Review Committee found that the trial is not meeting its ...
(Reuters) -Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending ...
A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy ...